FNY Managed Accounts’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
FNY Managed Accounts's HAE Position: Q1 2018 in Review
FNY Managed Accounts reduced its Haemonetics (HAE) stake by 31% in Q1 2018, selling an estimated $1.24K and leaving 40 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #390.
FNY Managed Accounts first reported a position in HAE in Q4 2017 and has held it in 2 quarters since. The position peaked at $3K in Q4 2017. 261 funds tracked by Wall St. Rank hold HAE as of Q1 2018.
- FNY Managed Accounts held 40 shares of Haemonetics worth $2K as of Q1 2018.
- FNY Managed Accounts sold 18 Haemonetics shares in Q1 2018, an estimated $1.24K.
- Haemonetics made up ﹤0.01% of FNY Managed Accounts's portfolio in Q1 2018, its #390 holding.
- FNY Managed Accounts first reported a position in Haemonetics in Q4 2017 and has held it in 2 quarters since.
- FNY Managed Accounts's Haemonetics position peaked at $3K in Q4 2017.
- 261 funds tracked by Wall St. Rank held Haemonetics as of Q1 2018.
Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.